α-Synuclein oligomers oppose long-term potentiation and impair memory through a calcineurin-dependent mechanism: relevance to human synucleopathic diseases
Journal of Neurochemistry; 120: 440–452. 2012 Feb; doi: 10.1111/j.1471-4159.2011.07576.x.
α-Synuclein potentiates interleukin-1β-induced CXCL10 expression in human A172 astrocytoma cells
Neuroscience Letters; Volume 507, Issue 2, 24 January 2012, Pages 133–136 DOI:10.1016/j.neulet.2011.12.001.
The acute inflammatory response to intranigral a-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation
J Neuroinflammation. 2011 Nov 28:8:166. doi: 10.1186/1742-2094-8-166.
The fusogenic tilted peptide (67–78) of α-synuclein is a cholesterol binding domain
Biochim Biophys Acta. 2011 Oct;1808(10):2343-51. doi: 10.1016/j.bbamem.2011.06.017
Quantitative, Label-Free Detection of the Aggregation of α-Synuclein Using Microcantilever Arrays Operated in a Liquid Environment
Journal of Sensors; http://dx.doi.org/10.1155/2012/874086.
Blockade of enzyme activity inhibits tissue transglutaminase-mediated transamidation of α-synuclein in a cellular model of Parkinson's disease.
Neurochemistry International; Volume 58, Issue 7, June 2011, Pages 785–793 DOI: 10.1016/j.neuint.2011.03.004.
PAMAM G4 dendrimers affect the aggregation of α-synuclein
International Journal of Biological Macromolecules; Volume 48, Issue 5, 2011 June 1, Pages 742–746; DOI: 10.1016/j.ijbiomac.2011.02.021
Molecular Basis for the Glycosphingolipid-Binding Specificity of α-Synuclein: Key Role of Tyrosine 39 in Membrane Insertion
Journal of Molecular Biology; Volume 408, Issue 4, 13 May 2011, Pages 654–669; DOI: 10.1016/j.bbr.2011.03.031
Role of Matrix Metalloproteinase 3-mediated α-Synuclein Cleavage in Dopaminergic Cell Death
J Biol Chem.; 2011 Apr 22;286(16):14168-77
Single Vesicle Observations of the Cardiolipin−Cytochrome c Interaction: Induction of Membrane Morphology Changes
Langmuir; 2011 April 19, 27 (10), pp 6107–6115 DOI: 10.1021/la104924c.